Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary …

determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Background—Chronic thromboembolic pulmonary hypertension results from incomplete
resolution of pulmonary emboli. Pulmonary endarterectomy (PEA) is potentially curative, but …

Background—Chronic thromboembolic pulmonary hypertension, a rare complication of
acute pulmonary embolism, is characterized by fibrothrombotic obstructions of large …

Background—Chronic thromboembolic pulmonary hypertension (CTEPH) is often a sequel
of venous thromboembolism with fatal natural history; however, many cases can be cured by …

Background—Although balloon pulmonary angioplasty (BPA) for inoperable patients with
chronic thromboembolic pulmonary hypertension was first reported over a decade ago, its …

Pulmonary hypertension (PH) is a heterogeneous condition. To date, no registry data exists
reflecting the spectrum of disease across the five diagnostic groups encountered in a …

Background—Balloon pulmonary angioplasty (BPA) is an alternative therapy for patients
with chronic thromboembolic pulmonary hypertension who are ineligible for standard …

Pulmonary hypertension (PH) is a progressive disease with a poor prognosis. Identifying
chronic thromboembolic pulmonary disease as a cause of PH has major clinical implications …

BACKGROUND: The incidence of pulmonary hypertension resulting from chronic thrombotic
occlusion of the pulmonary arteries is significantly underestimated. Although medical …